These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33990633)

  • 41. Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma.
    Wang L; Chi PD; Chen H; Xiang J; Xia ZJ; Zhang YJ
    Tumour Biol; 2014 Mar; 35(3):2141-9. PubMed ID: 24122233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of prognostic nutritional index on extranodal natural killer/T-cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working Group.
    Shen Z; Zhang S; Chen X; Zhang Q; Jiao Y; Shi Y; Zhang H; Ye J; Wang L; Zhu T; Miao Y; Wang L; Cai G; Sang W
    Hematol Oncol; 2023 Aug; 41(3):380-388. PubMed ID: 36680513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.
    Wang L; Wang H; Li PF; Lu Y; Xia ZJ; Huang HQ; Zhang YJ
    Ann Hematol; 2015 Aug; 94(8):1381-8. PubMed ID: 25865943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Jiang M; Wu WC; Zou LQ
    Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type.
    Chen R; Lu M; Wang J; Zhang D; Lin H; Zhu H; Zhang W; Xiong L; Ma J; Mao Y; Zhu J; Xu J
    Virchows Arch; 2013 Nov; 463(5):713-9. PubMed ID: 23979406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type.
    Cai Q; Luo X; Liang Y; Rao H; Fang X; Jiang W; Lin T; Lin T; Huang H
    Br J Cancer; 2013 Feb; 108(2):380-6. PubMed ID: 23299534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type.
    Yao N; Hou Q; Liang Y; Cao X; Sun B; Wei L; Sun R; Cao J
    Cancer Biomark; 2024; 39(4):265-275. PubMed ID: 38108343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laryngeal Extranodal Nasal-type Natural Killer/T-cell Lymphoma: A Clinicopathologic Study of 31 Cases in China.
    Xiang CX; Chen ZH; Zhao S; Gao LM; Tao Q; Zuo Z; Liu XY; Liu WP
    Am J Surg Pathol; 2019 Jul; 43(7):995-1004. PubMed ID: 31045893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia.
    Liang JH; Wang WT; Du KX; Xing TY; Wang Y; Wang H; Liu L; Guo R; Shao Y; Liang J; Li Y; Shen HR; Wang L; Li JY; Xu W
    Hum Cell; 2023 Mar; 36(2):835-846. PubMed ID: 36520345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma.
    Tian XP; Zhang YC; Lin NJ; Wang L; Li ZH; Guo HG; Ma SY; An MJ; Yang J; Hong YH; Wang XH; Zhou H; Li YJ; Rao HL; Li M; Hu SX; Lin TY; Li ZM; Huang H; Liang Y; Xia ZJ; Lv Y; Liu YY; Duan ZH; Chen QY; Wang JN; Cai J; Xie Y; Ong CK; Liu F; Liu YY; Yan Z; Huang L; Tao R; Li WY; Huang HQ; Cai QQ
    Cell Rep Med; 2023 Feb; 4(2):100859. PubMed ID: 36812892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathologic features and survival outcomes of CD30 expression in extranodal natural killer/T-cell lymphoma.
    Shen Z; Wang Y; Xie R; Zhang Q; Xing X; Zhang S; Liu H; Sang W
    Am J Clin Pathol; 2024 Jul; 162(1):95-102. PubMed ID: 38387041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review.
    Kim SJ; Yoon SE; Kim WS
    J Hematol Oncol; 2018 Dec; 11(1):140. PubMed ID: 30567593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pegaspargase Combined with Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Two-Center Phase II Study.
    Wang H; Wang L; Li C; Wuxiao Z; Chen G; Luo W; Lu Y
    Oncologist; 2020 Nov; 25(11):e1725-e1731. PubMed ID: 32627928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
    Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
    Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
    Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
    Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).
    Haverkos BM; Coleman C; Gru AA; Pan Z; Brammer J; Rochford R; Mishra A; Oakes CC; Baiocchi RA; Freud AG; Porcu P
    Discov Med; 2017 Mar; 23(126):189-199. PubMed ID: 28472613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
    Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients.
    Su C; Nguyen KA; Bai HX; Balaji D; Cao Y; Karakousis G; Zhang PJ; Zhang G; Xiao R
    Leuk Lymphoma; 2018 Jun; 59(6):1406-1412. PubMed ID: 28980517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignant effusions from extranodal NK/T-cell lymphomas are frequently of anaplastic morphology with azurophilic granules and of T-cell lineage.
    Liu CY; Chen BJ; Chuang SS;
    Diagn Cytopathol; 2020 May; 48(5):453-463. PubMed ID: 32020785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.